Drug Type Small molecule drug |
Synonyms IDX 320, IDX320 |
Target |
Mechanism NS3 inhibitors(Hepatitis C virus (HCV) nonstructural protein 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1/2 |
First Approval Date- |
Regulation- |
Molecular FormulaC37H43F3N6O7S2 |
InChIKeyYEPBUHWNLNKZBW-FDVAVYTKSA-N |
CAS Registry1251165-81-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Phase 2 | HU | - | |
Hepatitis C | Phase 2 | NL | - | |
Hepatitis C | Phase 2 | PL | - | |
Hepatitis C, Chronic | Phase 1 | - | 01 Jun 2010 |